‘This latest patent adds to Prescient’s considerable patent estate, and provides Prescient with intellectual property protection covering its lead compound for the treatment of patients with cancer that overexpresses Akt.’
Excellent addition to the patent ‘estate.’
Commendable behind the scenes achievement,
as now almost expected by this blue chip team.
Well done.
Ann: Canadian Patent Granted for PTX-200, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.2¢ | 4.0¢ | $43.30K | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1110555 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 60000 | 1 |
View Market Depth
| Last trade - 14.47pm 04/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |